GO:0030212 hyaluronan metabolic process: Biosynthesis, Turnover, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030212 (hyaluronan metabolic process) describes the chemical reactions and pathways that build and break down hyaluronan, a non-sulfated glycosaminoglycan made of repeating beta(1,4)-D-glucuronic acid-beta(1,3)-N-acetyl-D-glucosamine disaccharide units.
• Hyaluronan synthesis is carried out by hyaluronan synthases (HAS1, HAS2, HAS3) at the plasma membrane, using UDP-glucuronic acid and UDP-N-acetylglucosamine as substrates.
• Hyaluronan turnover is driven by hyaluronidases (HYAL1, HYAL2, HYAL3, PH20/SPAM1) and by oxidative and mechanical fragmentation, producing fragments with distinct signaling activities.
• Hyaluronan metabolism is tightly coupled to cell energy metabolism, including glycolysis and hexosamine biosynthesis, which supply the sugar nucleotide precursors.
• Intracellular hyaluronan and its fragments participate in cell signaling, motility, and stress responses, expanding the functional scope of this GO term beyond the extracellular matrix.
• Manipulating hyaluronan synthesis, for example by increasing Has2 expression, has been linked to improved healthspan in mouse models, highlighting translational interest in this pathway.
Description
GO:0030212, hyaluronan metabolic process, is the biological process that encompasses the chemical reactions and pathways involving hyaluronan, the naturally occurring anionic form of hyaluronic acid. Hyaluronan is a non-sulfated glycosaminoglycan composed of repeating disaccharide units of beta(1,4)-D-glucuronic acid and beta(1,3)-N-acetyl-D-glucosamine, and it is a major component of the extracellular matrix in many tissues. Because hyaluronan is not attached to a core protein, its metabolism is distinct from that of proteoglycans and depends on dedicated synthases and hyaluronidases. Researchers study this process to understand tissue hydration, matrix remodeling, inflammation, cancer progression, and aging-related phenotypes. The balance between hyaluronan synthesis and degradation determines the molecular weight distribution of hyaluronan, which in turn influences its biological functions. This article summarizes the definition, mechanisms, key genes, disease links, and experimental approaches relevant to GO:0030212, based on published literature and the QuickGO definition.
hyaluronan metabolic process At A Glance
| GO ID | GO:0030212 |
|---|---|
| GO term | hyaluronan metabolic process |
| Ontology | biological_process |
| Synonym | hyaluronan metabolism |
| Definition | The chemical reactions and pathways involving hyaluronan, the naturally occurring anionic form of hyaluronic acid; hyaluronan is a non-sulfated glycosaminoglycan composed of the repeating disaccharide unit beta(1,4)-D-glucuronic acid-beta(1,3)-N-acetyl-D-glucosamine. |
| Major function | Synthesis, assembly, and degradation of hyaluronan, a key extracellular matrix glycosaminoglycan. |
| Key enzymes | Hyaluronan synthases (HAS1, HAS2, HAS3) for synthesis; hyaluronidases (HYAL1, HYAL2, HYAL3, PH20/SPAM1) for degradation. |
| Substrates | UDP-glucuronic acid and UDP-N-acetylglucosamine. |
| Related processes | Glycosaminoglycan metabolism, extracellular matrix organization, cell adhesion, inflammation. |
What Is GO:0030212?
In simple terms, GO:0030212 describes all the reactions that make, modify, and break down hyaluronan in a cell or organism. Hyaluronan is a long, unbranched sugar polymer built from two alternating sugars, glucuronic acid and N-acetylglucosamine, and it is not sulfated. The process includes the synthesis of the hyaluronan polymer by hyaluronan synthases, its release into the extracellular space, its interaction with binding proteins, and its degradation by hyaluronidases and other mechanisms. The term also covers the metabolic interconversion of precursors such as UDP-glucuronic acid and UDP-N-acetylglucosamine that feed into hyaluronan production. Because hyaluronan can exist in different molecular sizes, the process includes the generation of fragments that can act as signaling molecules.
Why Is hyaluronan metabolic process Important in Cell Biology?
Hyaluronan metabolic process is important because hyaluronan is a central structural and signaling molecule in the extracellular matrix, and its metabolism influences tissue hydration, cell migration, inflammation, and cancer progression. Dysregulated hyaluronan synthesis or degradation is associated with numerous pathologies, including cancer, fibrosis, and inflammatory diseases. Because hyaluronan metabolism is linked to cellular energy status and nutrient availability, it also connects metabolic pathways to matrix remodeling. Understanding GO:0030212 therefore provides insight into both normal physiology and disease mechanisms, and it offers potential targets for therapeutic intervention.
• Hyaluronan is a major component of the extracellular matrix and regulates tissue hydration and viscoelasticity.
• Hyaluronan synthases are regulated by metabolic cues, linking hyaluronan production to cell energy metabolism.
• Hyaluronan fragments can act as signaling molecules that promote inflammation and cell migration.
• Turnover of hyaluronan by hyaluronidases is essential for matrix remodeling and tissue homeostasis.
• Altered hyaluronan metabolism is observed in many cancers and contributes to tumor progression.
• Manipulation of hyaluronan synthesis can affect healthspan and aging-related phenotypes in animal models.
• Hyaluronan metabolism is relevant to developmental processes, wound healing, and regeneration.
• Intracellular hyaluronan has been implicated in cell cycle regulation and stress responses.
• Hyaluronan metabolism intersects with glycosaminoglycan biosynthesis and hexosamine pathway.
• Targeting hyaluronan metabolism is being explored for therapeutic applications in oncology and fibrosis.
What Happens During hyaluronan metabolic process?
Synthesis of hyaluronan by hyaluronan synthases
In simple terms: Cells build hyaluronan by linking two types of sugar molecules together in a long chain.
Hyaluronan synthesis is catalyzed by hyaluronan synthases (HAS1, HAS2, and HAS3), which are membrane-bound enzymes that alternately add glucuronic acid and N-acetylglucosamine from UDP-sugar donors to the growing polymer. The nascent hyaluronan chain is extruded through the plasma membrane into the extracellular space, and the enzymes use UDP-glucuronic acid and UDP-N-acetylglucosamine as substrates. The activity of these enzymes is influenced by the availability of these sugar nucleotides, which are supplied by cellular metabolism.
Regulation of hyaluronan synthesis by metabolic and signaling cues
In simple terms: The production of hyaluronan is turned up or down depending on the cell's energy and nutrient status.
Hyaluronan synthesis is metabolically controlled; the supply of UDP-glucuronic acid and UDP-N-acetylglucosamine depends on glycolysis and the hexosamine biosynthetic pathway, and changes in energy metabolism can affect HAS activity. Growth factors and cytokines can also modulate HAS expression and activity, thereby altering hyaluronan production. This regulation ensures that hyaluronan synthesis is coordinated with cellular metabolic state.
Extracellular hyaluronan and its interactions
In simple terms: Once outside the cell, hyaluronan can bind to proteins and form large networks that affect tissue structure.
After synthesis, hyaluronan can interact with hyaladherins such as CD44 and RHAMM, which mediate cell adhesion, migration, and signaling. The high molecular weight form of hyaluronan contributes to matrix organization and tissue hydration, while smaller fragments can have different biological activities. These interactions are part of the hyaluronan metabolic process because they influence the availability and function of hyaluronan.
Degradation and turnover of hyaluronan
In simple terms: Hyaluronan is broken down into smaller pieces by enzymes called hyaluronidases and by other mechanisms.
Hyaluronan turnover is mediated by hyaluronidases, including HYAL1, HYAL2, HYAL3, and PH20/SPAM1, which cleave the polymer into fragments of varying sizes. In addition, reactive oxygen species and mechanical forces can fragment hyaluronan. The resulting fragments can be internalized and further degraded, and they may act as signaling molecules that influence inflammation, angiogenesis, and cell proliferation. The balance between synthesis and degradation determines the steady-state levels and molecular weight of hyaluronan in tissues.
Intracellular hyaluronan and its roles
In simple terms: Hyaluronan can also be found inside cells, where it may have additional functions.
Intracellular hyaluronan has been detected in various cell types, and it has been implicated in processes such as cell cycle progression, stress responses, and regulation of gene expression. The mechanisms by which hyaluronan enters cells and functions intracellularly are still being investigated, but they expand the scope of hyaluronan metabolism beyond the extracellular matrix. This intracellular pool may also contribute to the overall turnover of hyaluronan.
Key Genes Involved in GO:0030212 hyaluronan metabolic process
The following genes encode enzymes and proteins directly involved in hyaluronan metabolic process, including synthases, hyaluronidases, and related metabolic enzymes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HAS1 | Hyaluronan synthase that produces hyaluronan polymers | Studied for its role in hyaluronan synthesis and matrix production |
| HAS2 | Major hyaluronan synthase in many tissues; produces high molecular weight hyaluronan | Target for manipulating hyaluronan levels; linked to healthspan in mice |
| HAS3 | Hyaluronan synthase that produces shorter hyaluronan chains | Investigated for its role in cell proliferation and migration |
| HYAL1 | Hyaluronidase that degrades hyaluronan | Studied in cancer and lysosomal storage disorders |
| HYAL2 | Hyaluronidase that cleaves high molecular weight hyaluronan | Implicated in hyaluronan turnover and receptor-mediated uptake |
| HYAL3 | Hyaluronidase with roles in hyaluronan catabolism | Less characterized; potential role in turnover |
| PH20 (SPAM1) | Hyaluronidase involved in fertilization and tissue remodeling | Studied in reproduction and cancer |
| CD44 | Hyaluronan receptor that mediates cell adhesion and signaling | Key player in hyaluronan signaling and cancer progression |
| RHAMM (HMMR) | Hyaluronan receptor involved in cell motility and signaling | Studied in cancer and cell migration |
| UGDH | Enzyme in UDP-glucuronic acid synthesis | Provides substrate for hyaluronan synthesis |
| GFPT1 | Enzyme in hexosamine pathway for UDP-GlcNAc synthesis | Supplies substrate for hyaluronan synthesis |
| GNPNAT1 | Enzyme in hexosamine biosynthetic pathway | Contributes to UDP-GlcNAc production |
| PGM3 | Enzyme in UDP-GlcNAc synthesis | Metabolic support for hyaluronan synthesis |
| UAP1 | Enzyme that converts UDP-GlcNAc to UDP-GlcNAc | Involved in sugar nucleotide metabolism |
| HAS2-AS1 | Long non-coding RNA antisense to HAS2 | Regulates HAS2 expression and hyaluronan synthesis |
| HABP2 | Hyaluronan-binding protein | May influence hyaluronan turnover |
| ITIH1 | Inter-alpha-trypsin inhibitor heavy chain | Can bind hyaluronan and affect matrix stability |
| TNFIP6 | Hyaluronan-binding protein | Involved in extracellular matrix organization |
How Is hyaluronan metabolic process Regulated?
Hyaluronan metabolic process is regulated at multiple levels. The expression and activity of hyaluronan synthases are influenced by growth factors, cytokines, and metabolic signals, including the availability of UDP-sugar precursors from glycolysis and the hexosamine pathway. Energy status can affect hyaluronan synthesis, as the process requires ATP and sugar nucleotides. Hyaluronidases are regulated by gene expression, pH, and the presence of inhibitors, and their activity determines the rate of hyaluronan turnover. Additionally, hyaluronan-binding proteins and receptors can modulate the stability and signaling of hyaluronan. Overall, the balance between synthesis and degradation is tightly controlled to maintain tissue homeostasis.
hyaluronan metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HAS2 | Cancer progression and aging | HAS2 knockout or overexpression in cancer cell lines and mouse models |
| HYAL1 | Cancer and lysosomal storage | HYAL1 knockout or knockdown in tumor cells |
| CD44 | Cancer metastasis and inflammation | CD44 knockout mice or cell lines |
| RHAMM | Cancer cell motility | RHAMM knockout or knockdown in migration assays |
| UGDH | Metabolic disorders affecting matrix | UGDH knockout or point mutation in metabolic cell models |
Hyaluronan metabolism in cancer
Altered hyaluronan metabolism is a common feature of many cancers, where increased hyaluronan synthesis and accumulation are associated with tumor progression, metastasis, and poor prognosis. Hyaluronan fragments can promote signaling pathways that enhance cell proliferation, migration, and angiogenesis. Hyaluronidases may also play context-dependent roles in cancer, sometimes promoting invasion. Targeting hyaluronan metabolism is being explored as a therapeutic strategy in oncology.
Hyaluronan metabolism in inflammatory and fibrotic diseases
Hyaluronan accumulation and fragmentation are linked to inflammation and fibrosis in various tissues. Low molecular weight hyaluronan can act as a danger signal that activates immune cells, while high molecular weight hyaluronan can be anti-inflammatory. Dysregulated hyaluronan turnover contributes to chronic inflammatory conditions and fibrotic remodeling. Modulating hyaluronan metabolism is therefore of interest for treating these disorders.
Hyaluronan metabolism in aging and metabolic disorders
Hyaluronan metabolism has been implicated in aging and metabolic regulation. For example, increasing hyaluronan levels by expressing the naked mole-rat Has2 in mice improved healthspan, suggesting a role in aging-related pathways. Metabolic disorders such as diabetes can affect hyaluronan synthesis through altered glucose metabolism and hexosamine pathway flux. These findings highlight the interplay between hyaluronan metabolism and systemic metabolism.
From hyaluronan metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of loss of HAS2 on hyaluronan synthesis? | HAS2 knockout cell line (CRISPR KO) |
| How does a point mutation in HYAL1 affect its catalytic activity? | HYAL1 point-mutation knock-in cell line |
| Can overexpression of Has2 increase hyaluronan levels and affect healthspan? | Has2 overexpression mouse model |
| What is the role of CD44 in hyaluronan-mediated signaling? | CD44 knockout or tagged knock-in cell line |
| How does metabolic flux affect hyaluronan synthesis? | Knockout of UGDH or GFPT1 in metabolic cell models |
| What are the interacting partners of HAS2? | Tagged knock-in of HAS2 for proteomics |
How to Study the hyaluronan metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA-like assay | Hyaluronan concentration | Quantifying hyaluronan in cell culture or tissue extracts |
| Size-exclusion chromatography | Molecular weight distribution of hyaluronan | Assessing changes in polymer size after enzyme treatment |
| Hyaluronan synthase activity assay | Enzyme activity using radiolabeled substrates | Characterizing HAS mutants or expression levels |
| Hyaluronidase activity assay | Degradation of hyaluronan | Evaluating HYAL function and inhibitors |
| RNA-seq | Transcript levels of HAS, HYAL, and metabolic genes | Profiling hyaluronan metabolism under different conditions |
| Immunofluorescence | Localization of hyaluronan and HAS proteins | Visualizing hyaluronan in tissues and cells |
| CRISPR knockout screening | Genes affecting hyaluronan levels | Identifying novel regulators of hyaluronan metabolism |
| Proteomics | Protein interactions with HAS or hyaluronan | Mapping the hyaluronan interactome |
Measuring hyaluronan levels and molecular weight
Hyaluronan can be quantified using colorimetric assays, ELISA-like methods, or mass spectrometry, and its molecular weight distribution can be analyzed by gel electrophoresis or size-exclusion chromatography. These methods are essential to assess the outcome of genetic or pharmacological perturbations of hyaluronan metabolism.
Enzyme activity assays for hyaluronan synthases and hyaluronidases
Hyaluronan synthase activity can be measured in membrane fractions using radiolabeled UDP-sugar substrates, while hyaluronidase activity can be assayed using hyaluronan substrates and detection of degradation products. These assays help determine the functional impact of mutations or expression changes.
Gene expression analysis by RNA-seq and qPCR
RNA sequencing and quantitative PCR can be used to measure the expression of HAS genes, hyaluronidases, and related metabolic enzymes under different conditions. This approach reveals transcriptional regulation of hyaluronan metabolism.
Imaging and localization studies
Hyaluronan can be visualized in tissues using hyaluronan-binding proteins (e.g., HABP) or specific antibodies, and fluorescent tagging of HAS proteins allows live-cell imaging of synthesis sites. These methods provide spatial information about hyaluronan metabolism.
How CRISPR Can Be Used to Study GO:0030212 hyaluronan metabolic process
Knockout
CRISPR knockout of HAS genes, hyaluronidases, or metabolic enzymes can be used to determine their essential roles in hyaluronan metabolism. For example, HAS2 knockout cells show reduced hyaluronan synthesis, while HYAL1 knockout cells accumulate hyaluronan. These models help establish causality between specific genes and hyaluronan-related phenotypes.
Point Mutation
Point mutations can be introduced into catalytic residues of HAS or HYAL enzymes to dissect their enzymatic mechanisms without completely abolishing protein expression. Such models are valuable for studying the impact of specific amino acid changes on hyaluronan synthesis or degradation.
Knock-in
Knock-in of tagged versions of HAS or HYAL proteins (e.g., GFP or HA tags) allows visualization and purification of these enzymes for interaction and localization studies. Knock-in of disease-associated mutations can also model human conditions related to hyaluronan metabolism.
Overexpression
Overexpression of HAS genes, particularly HAS2, can increase hyaluronan production and has been used to study the effects of elevated hyaluronan on cell behavior and organismal healthspan. Overexpression models complement knockout studies by revealing gain-of-function phenotypes.
How EDITGENE Supports hyaluronan metabolic process Research
Researchers studying hyaluronan metabolic process-related genes often need to determine whether a candidate gene is causally involved in hyaluronan synthesis, turnover, or signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models that enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for hyaluronan metabolic process research.
Frequently Asked Questions About hyaluronan metabolic process
What is GO:0030212 hyaluronan metabolic process?
GO:0030212 is a Gene Ontology biological process term that describes the chemical reactions and pathways involving hyaluronan, a non-sulfated glycosaminoglycan composed of repeating disaccharide units.
What genes are involved in hyaluronan metabolic process?
Key genes include hyaluronan synthases (HAS1, HAS2, HAS3), hyaluronidases (HYAL1, HYAL2, HYAL3, PH20/SPAM1), hyaluronan receptors (CD44, RHAMM), and metabolic enzymes such as UGDH and GFPT1.
How is hyaluronan synthesized?
Hyaluronan is synthesized by hyaluronan synthases at the plasma membrane using UDP-glucuronic acid and UDP-N-acetylglucosamine as substrates, and the polymer is extruded into the extracellular space.
What enzymes degrade hyaluronan?
Hyaluronidases, including HYAL1, HYAL2, HYAL3, and PH20/SPAM1, cleave hyaluronan into fragments; reactive oxygen species can also fragment hyaluronan.
Why is hyaluronan metabolism important in cancer?
Altered hyaluronan metabolism is associated with tumor progression, metastasis, and poor prognosis, and hyaluronan fragments can promote signaling pathways that enhance cell proliferation and migration.
How can I study hyaluronan metabolic process in the lab?
Common methods include hyaluronan quantification assays, enzyme activity assays, RNA-seq, immunofluorescence, and CRISPR-based genetic screens.
What is the link between hyaluronan metabolism and aging?
Increasing hyaluronan levels by expressing naked mole-rat Has2 in mice improved healthspan, suggesting a role for hyaluronan metabolism in aging-related pathways.
Can CRISPR be used to study hyaluronan metabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the roles of specific genes in hyaluronan synthesis and turnover.
What are the substrates for hyaluronan synthesis?
The substrates are UDP-glucuronic acid and UDP-N-acetylglucosamine, which are supplied by cellular metabolic pathways including glycolysis and the hexosamine pathway.
What is the role of CD44 in hyaluronan metabolism?
CD44 is a hyaluronan receptor that mediates cell adhesion and signaling in response to hyaluronan, influencing processes such as migration and inflammation.
Conclusion
GO:0030212 hyaluronan metabolic process encompasses the synthesis, regulation, and degradation of hyaluronan, a critical glycosaminoglycan in the extracellular matrix and beyond. The process is driven by hyaluronan synthases and hyaluronidases, and it is tightly linked to cellular metabolism and signaling. Dysregulation of hyaluronan metabolism contributes to cancer, inflammation, and aging-related phenotypes, making it a compelling area of research. Advances in CRISPR-based models and analytical methods continue to illuminate the mechanistic details of this pathway, offering opportunities for therapeutic intervention.
References
- 1. Zhang Z et al.. 2023. Increased hyaluronan by naked mole-rat Has2 improves healthspan in mice.. Nature 621(7977):196-205 PMID: 37612507
- 2. Vigetti D et al.. 2014. Metabolic control of hyaluronan synthases.. Matrix Biol 35:8-13 PMID: 24134926
- 3. Laurent TC. 1987. Biochemistry of hyaluronan.. Acta Otolaryngol Suppl 442:7-24 PMID: 3124495
- 4. Caon I et al.. 2021. Cell Energy Metabolism and Hyaluronan Synthesis.. J Histochem Cytochem 69(1):35-47 PMID: 32623953
- 5. Skandalis SS et al.. 2020. Intracellular hyaluronan: Importance for cellular functions.. Semin Cancer Biol 62:20-30 PMID: 31276783
- 6. Vigetti D et al.. 2014. Hyaluronan: biosynthesis and signaling.. Biochim Biophys Acta 1840(8):2452-9 PMID: 24513306
- 7. Fraser JR et al.. 1989. Turnover and metabolism of hyaluronan.. Ciba Found Symp 143:41-53; discussion 53-9, 281-5 PMID: 2680348
- 8. Simpson MA et al.. 2014. Hyaluronan signaling and turnover. Preface.. Adv Cancer Res 123:xv-xvi PMID: 25081537
